Prescient Therapeutics Ltd: Notice of Annual General Meeting/Proxy Form
Prescient Therapeutics Ltd: Prescient CEO to step down in early 2025
Prescient Therapeutics Ltd: PTX Presentation
Prescient Therapeutics Ltd: PTX appoints Dr Gavin Shepherd as Non-Executive Director
Prescient Therapeutics Ltd: PTX-100 Spotlight Presentation
Prescient Therapeutics Ltd: Results of Annual General Meeting
Prescient Therapeutics Ltd: Chair and CEO AGM Presentation
Prescient Therapeutics Ltd: Notice of Annual General Meeting/Proxy Form
Prescient Therapeutics Ltd: Experienced Pharma Executive Joins Prescient Board
Prescient Therapeutics Ltd: Notification of Expiry of Listed Options
Prescient Therapeutics Ltd: Results of Annual General Meeting
Prescient Therapeutics Ltd: AGM Presentation
Prescient Therapeutics Ltd: PTX Investor presentation and additional patient response
Prescient Therapeutics Ltd: Notice of Annual General Meeting/Proxy Form
Prescient Therapeutics Ltd: CellPryme-A Investor Presentation
Prescient Therapeutics Ltd: Share Purchase Plan Booklet
Prescient Therapeutics Ltd: PTX Presentation
Prescient Therapeutics Ltd: PTX CellPryme-M presentation
Prescient Therapeutics Ltd: Prescient to Present at AVID 2022 Meeting
Prescient Therapeutics Ltd: Investor Presentation
No Data
No Data